Cipher Pharma (CPH.TO) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cipher Pharma (CPH.TO)

CPH.TO 15.10

+0.7%

12:58 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 PreviousNext

From: BioHero	10/18/2019 8:12:21 AM
	of 6

APPROOOOOVED Cipher Pharmaceuticals Receives Health Canada Approval For Trulance® (Plecanatide)..Oct. 18, 2019 finance.yahoo.com It is estimated that one in four Canadians has symptoms of constipation and an estimated 38% of Canadians report constipation within the previous 12 months.[B]According to IQVIA the total Canadian laxative and antispasmodic market (prescription and OTC) was valued at over CDN $200 million for the 12 months ending December 2018[/B] . Cipher acquired the Canadian rights to develop, market, distribute and sell TRULANCE® from Bausch Health Companies Inc.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 PreviousNext